AI assistant
INSMED Inc — Director's Dealing 2025
Jul 15, 2025
30150_dirs_2025-07-15_fef0be0d-7f9e-4e99-8c8f-75c9ff93dbd4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2025-07-15
Reporting Person: Lewis William (Director, Chair and CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-15 | Common Stock | M | 6830 | $10.85 | Acquired | 240754 | Indirect |
| 2025-07-15 | Common Stock | S | 2168 | $101.71 | Disposed | 238586 | Indirect |
| 2025-07-15 | Common Stock | S | 4492 | $102.66 | Disposed | 234094 | Indirect |
| 2025-07-15 | Common Stock | S | 170 | $103.32 | Disposed | 233924 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-07-15 | Stock Option (right to buy) | $10.85 | M | 6830 | Disposed | 2026-05-19 | Common Stock (6830) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 303911 | Direct |
| Common Stock | 50500 | Indirect |
Footnotes
F1: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 12, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 2,168 shares sold at prices ranging from $101.10 to $102.09 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 4,492 shares sold at prices ranging from $102.13 to $103.12 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 170 shares sold at prices ranging from $103.14 to $103.37 per share. The Reporting Person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.